Coherus BioSciences will see its workforce shrink once again as the result of the recently agreed sale of its Neulasta ...
Q4 2024 Earnings Call Transcript March 10, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback